(Q46891104)

26 December 2017

title

N2-carboxyethyl-2'-deoxyguanosine, a DNA glycation marker, in kidneys and aortas of diabetic and uremic patients (English)

1 reference

26 December 2017

author name string

Li H

1

1 reference

26 December 2017

Nakamura S

2

1 reference

26 December 2017

Miyazaki S

3

1 reference

26 December 2017

Morita T

4

1 reference

26 December 2017

Suzuki M

5

1 reference

26 December 2017

Pischetsrieder M

6

1 reference

26 December 2017

Niwa T

7

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

26 December 2017

published in

Kidney International

1 reference

26 December 2017

volume

69

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

388-392

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000064

exact match

0 references

cites work

Involvement of Maillard reactions in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Increased levels of advanced glycation end products in human cataractous lenses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

New biomarkers of Maillard reaction damage to proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Advanced glycation end products in clinical nephrology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Role of advanced glycation end products in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

The involvement of advanced glycation endproducts (AGEs) in renal injury of diabetic glomerulosclerosis: association with phenotypic change in renal cells and infiltration of immune cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Association between pentosidine and arteriosclerosis in patients receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Reaction of guanosine with glucose under oxidative conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Determination of glycated nucleobases in human urine by a new monoclonal antibody specific for N2-carboxyethyl-2'-deoxyguanosine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Immunochemical detection of N2-[1-(1-carboxy)ethyl]guanosine, an advanced glycation end product formed by the reaction of DNA and reducing sugars or L-ascorbic acid in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

N(2)-(1-Carboxyethyl)deoxyguanosine, a nonenzymatic glycation adduct of DNA, induces single-strand breaks and increases mutation frequencies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Modification of DNA by glucose 6-phosphate induces DNA rearrangements in an Escherichia coli plasmid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Transposition of an Alu-containing element induced by DNA-advanced glycosylation endproducts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

The Maillard hypothesis on aging: time to focus on DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Cancer in end-stage renal disease: potential factors involved -editorial-

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000064

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000064

1 reference

26 December 2017

PubMed ID

16408131

1 reference

26 December 2017